Xyall raises €7.6M Series C round

11 February 2026· Eindhoven, The Netherlands· health, diagnostics, robotics, ai, b2b, software_hardware

The funding will support the global roll out of Xyall's Tissector TableTop, an automated tissue dissection system that is already in use at more than 15 molecular pathology laboratories in the United States.

Investors

LeadCapricorn Partners
Also participating
BOM Brabant VenturesSioux TechnologiesHealth Investment Partners

About Xyall

Stage
Series C
Headquarters
Eindhoven, The Netherlands
Founded
2018
Team Size
21–50
Sectors
healthdiagnosticsroboticsaib2bsoftware_hardware

Source: https://www.capricorn.be/news/medtech-innovator-xyall-closes-e-7-6-million-financing-round-to-globally-roll-out-its-unique-high-tech-molecular-pathology-laboratory-solutions/